Natrium-(5Z,13E,15S)-6,9α-epoxy-11α,15-dihydroxyprosta-5,13-dien-1-oat
|
|
|
- CAS-Nr.
- 61849-14-7
- Bezeichnung:
- Natrium-(5Z,13E,15S)-6,9α-epoxy-11α,15-dihydroxyprosta-5,13-dien-1-oat
- Englisch Name:
- PROSTACYCLIN SODIUM SALT
- Synonyma:
- PGI2;Flolan;PG12-NA;PGI2-NA;PGI2 sodium;Sodium PGI2;EPOPROSTENOL;Eprostol sodium;PROSTAGLANDIN I2;Prostaglandin 12
- CBNumber:
- CB8167138
- Summenformel:
- C20H33NaO5
- Molgewicht:
- 376.47
- MOL-Datei:
- 61849-14-7.mol
|
Natrium-(5Z,13E,15S)-6,9α-epoxy-11α,15-dihydroxyprosta-5,13-dien-1-oat Eigenschaften
- Schmelzpunkt:
- 168-170 °C
- RTECS-Nr.
- UK8008700
- storage temp.
- -20°C
- L?slichkeit
- H2O: 1 mg/mL Hydrolyzes to 6-ketoprostaglandin F1α in aqueous solution.
- Aggregatzustand
- powder
- Farbe
- white
- Biologische Quelle
- synthetic
- Wasserl?slichkeit
- Soluble to 100 mM in water
- Sensitive
- Moisture Sensitive
- Merck
- 13,7967
- BRN
- 6472195
- Stabilit?t:
- Light Sensitive, Temperature Sensitive
- CAS Datenbank
- 61849-14-7(CAS DataBase Reference)
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
| H312 |
Gesundheitssch?dlich bei Hautkontakt. |
Akute Toxizit?t dermal |
Kategorie 4 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P280,P302+P352, P312, P322, P363,P501 |
| H332 |
Gesundheitssch?dlich bei Einatmen. |
Akute Toxizit?t inhalativ |
Kategorie 4 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P261, P271, P304+P340, P312 |
|
| Sicherheit |
| P261 |
Einatmen von Staub vermeiden. |
| P280 |
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen. |
| P304+P340 |
BEI EINATMEN: Die Person an die frische Luft bringen und für ungehinderte Atmung sorgen. |
| P321 |
Besondere Behandlung |
|
Natrium-(5Z,13E,15S)-6,9α-epoxy-11α,15-dihydroxyprosta-5,13-dien-1-oat Chemische Eigenschaften,Einsatz,Produktion Methoden
R-S?tze Betriebsanweisung:
R20/21/22:Gesundheitssch?dlich beim Einatmen,Verschlucken und Berührung mit der Haut.
S-S?tze Betriebsanweisung:
S22:Staub nicht einatmen.
S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.
Beschreibung
Epoprostenol is a naturally occurring prostaglandin indicated for the preservation of platelet function during cardiopulmonary bypass, prevention of platelet aggregation during charcoal hemoperfusion of patients in hepatic failure, and as an alternative to heparin during renal dialysis.
Chemische Eigenschaften
Epoprostenol is white crystalline powder
Verwenden
Epoprostenol is an Eicosanoid which prevents the formation of platelet plugs and is an effective vasodilator.
Biologische Aktivit?t
Epoprostenol is a potent agonist at IP prostanoid receptors. Inhibits platelet aggregation and induces vasodilation.
Natrium-(5Z,13E,15S)-6,9α-epoxy-11α,15-dihydroxyprosta-5,13-dien-1-oat Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Natrium-(5Z,13E,15S)-6,9α-epoxy-11α,15-dihydroxyprosta-5,13-dien-1-oat Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 166)Lieferanten
61849-14-7(Natrium-(5Z,13E,15S)-6,9α-epoxy-11α,15-dihydroxyprosta-5,13-dien-1-oat)Verwandte Suche:
- Sodium (5Z,13E,15S)-6,9a-epoxy-11a,15-dihydroxyprosta-5,13-dien-1-oate
- cGMP Epoprostenol (sodium salt)
- (5Z,13E,8R,9S,11R,12R,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oicacidsodiumsalt
- Prostacyclin sodium salt Epoprostenol sodium
- PGI2Na (Prostaglandin I2Na, Prostacyclin)
- Prostaglandin I?, Sodium Salt
- EPOPROSTENOL
- EPOPROSTENOL SODIUM
- EPOPROSTENOL SODIUM SALT
- (5-Z)-9-DEOXY-6,9ALPHA-EPOXY-PGF1ALPHA, SODIUM SALT
- [5Z,9ALPHA,11ALPHA,13E,15S]-6,9-EPOXY-11,15-DIHYDROXYPROSTA-5,13-DIEN-1-OIC ACID SODIUM SALT
- 6,9ALPHA-EPOXY-11ALPHA,15S-DIHYDROXY-PROSTA-5Z,13E-DIEN-1-OIC ACID, SODIUM SALT
- PROSTACYCLINE SODIUM SALT
- PROSTACYCLIN SODIUM SALT
- PROSTAGLANDINS I2 SODIUM SALT
- PROSTAGLANDIN I2
- PROSTAGLANDIN I2 NA
- PROSTAGLANDIN I2 SODIUM SALT
- PG12-NA
- PGI2
- PGI2-NA
- PGI2, SODIUM SALT
- (5z,9α,11α,13e,15s)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid sodium salt
- Flolan
- PGI2 sodium
- Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, monosodium salt, (5Z,9α,11α,13E,15S)-
- Prostacyclin sodium
- Sodium PGI2
- Sodium prostacyclin
- Epoprostenol sodium salt, PGI2-Na, Prostacyclin sodium salt, (5Z,9α,11α,13E,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid sodium salt
- sodium (5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dien-1-oate
- PROSTAGLANDIN I2 SODIUM
- Prostaglandin 12
- (5-Z)-9-DEOXY-6,9ALPHA-EPOXY-PGF1ALPHA, SODIUM SALT, 98%, STABILIZED
- (5-Z)-9-Deoxy-6,9alpha-epoxy-PGF1alpha, sodium salt, stabilized
- (5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate
- Prostaglandin I, Sodium Salt - CAS 61849-14-7 - Calbiochem
- PROSTACYCLIN SODIUM SALT USP/EP/BP
- Epoprostenol sodiumQ: What is
Epoprostenol sodium Q: What is the CAS Number of
Epoprostenol sodium Q: What is the storage condition of
Epoprostenol sodium Q: What are the applications of
Epoprostenol sodium
- TIANFU CHEM--PROSTACYCLIN SODIUM SALT
- Epoprostenol Sodium (COLD SHIPMENT REQUIRED) (1237600)
- Eprostol sodium
- Prostaglandin I2 sodium salt, potent vasodilator
- Prostaglandin I2 sodium salt
- Epoprostenol ELISA Kit
- 61849-14-7
- C20H32NaO5
- C20H31O5Na
- C20H31NaO5
- Fatty Acids
- Lipids
- Prostaglandins
- Biochemicals and Reagents
- BioChemical
- Chiral Reagents
- Intermediates & Fine Chemicals
- Pharmaceuticals
